Factors such as extensive adoption of genetic engineering by research institutes and pharmaceutical companies, technological advancement in diagnostic technique, sensory technology enables the rapid analysis, rising awareness about molecular diagnostic testing driving the market growth of nucleic acid testing globally.

The report titled “Nucleic Acid Testing Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall nucleic acid testing market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on technology, application and different geographical regions.  

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global nucleic acid testing market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global nucleic acid testing market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global nucleic acid testing market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global nucleic acid testing market. This report concludes with company profiles section that highlights major information about the key players engaged in global nucleic acid testing market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.     

Thus, the research study provides a holistic view of the global nucleic acid testing market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on application, the global nucleic acid testing market is segmented as follows: 

• Infectious Diseases
• Genetic Disorders
• Cancer
• Forensic Testing
• Others (Blood screening, Mitochondrial Disorders)

Nucleic acid testing or nucleic acid amplification testing is generally abbreviated as NAT or NAAT. Variations exist in genome sequences of every individual; that makes NAT an ideal technique for identification of different disorders such as cancer, infectious diseases, genetic disorders, and mitochondrial disorders. Factors such as rapid, sensitive and specific methods compared to the traditional methods of diagnosis is driving the market growth of nucleic acid testing. NAT is widely used to detect and identify organisms for diagnosis, prognosis, and treatment of diseases. Previously NAT was used to screen HIV and HCV virus, however, its application has extended to detect human T-lymph tropic virus, treponema pallidum, hepatitis B virus, west nile virus, plasmodium and trypanosoma. It is observed that, in the base year 2016 infectious diseases held largest market share. NAT is capable of identifying genotypes and subtypes, determining resistance to particular antibiotics, and identifying viral load. All these factors are influencing the market growth of infectious disease segment. Some unique factors such as identification of fastidious bacteria, bacterial resistance testing, determination of bacterial infection after antibiotics are increasing the demand for NAT in identification of infectious disease. In recent years, NAT extensively used for early diagnosis of genetic variations and prevention of cancer. It is estimated that, NAT will play an important role in personalized and predictive medicine in future to avoid adverse reaction of medicines.

Based on technology, the global nucleic acid testing market is segmented as follows: 

• Polymerase chain reaction (PCR)
• Strand displacement amplification (SDA)
• Ligase chain reaction (LCR)
• Transcription-mediated amplification (TMA)
• Others (Nucleic acid sequence based amplification, Genome sequencing)

Nucleic acid test (NAT) is also known as nucleic acid amplification test (NAAT), is molecular technique used as screening method to detect genetic material such as DNA or RNA. NAT can detect pathogens, it is capable of detecting infectious donations faster than current tests because it detects genetic material rather than antigens or antibodies. Due to its accuracy and specificity demand for nucleic acid testing has increased in recent years. Sample extraction, amplification and target amplicon detection are the major process involved in NAT. Nucleic acid amplification perform by using three methods such as target amplification systems, probe amplification systems and signal amplification. It is observed that target amplification methods such as polymerase chain reaction, strand displacement amplification, ligase chain reaction and transcription-mediated amplification are most widely used in market. In the base year 2015, polymerase chain reaction was observed as the largest revenue generating segment as it is lower cost technique play fundamental role in disease detection, cloning, DNA typing, structural analysis, sequencing, mutation analysis and mapping.

For the purpose of this study, the nucleic acid testing market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)  

Nucleic acid testing is technique that involves amplification and detection of genetic material such as DNA or RNA. Variations exist in genome sequences of every individual, it makes NAT an ideal technique for detection of different disorder, prenatal screening and carrier screening. Technological advances in diagnostic method, increase in prevalence of infectious and genetic disease are driving the growth of NAT market. It is observed that NAT is widely accepted diagnostic technique in developed countries. Currently, NAT has been adopted in several countries such as Canada, France, Australia, New Zealand, South Africa, and other countries in Europe and Asia. In base year 2016, North America was largest contributor in global nucleic acid testing market and occupied a significant portion of the global market. United States observed as largest revenue generating market in North America. Factors such as technological advancement, extensive adoption of genetic engineering and higher investment in R&D activities driving the market growth of NAT in North America. Asia Pacific is anticipated to show fastest growth rate during forecast period. Factors such as improving economic condition, populous countries and increasing demand of NAT would drive the market growth in Asia Pacific region during forecast period.